Theo Heller, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
11
11
6
N/A
0
12
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Worked with same sponsors:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
Eric Bellissant, MD, PhD
Rennes University Hospital
Shared therapeutic areas:
Ed Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Worked with same sponsors:
John F Tisdale, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Gary Schiller, MD
University of California, Los Angeles
Shared therapeutic areas:
Rémi Rabasa-Lhoret
Institut de Recherches Cliniques de Montreal
Shared therapeutic areas:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Nigel Key, MD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Natural History of Noncirrhotic Portal Hypertension
Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
All 11 trials loaded